Хайлтын үр дүнгүүд - Helena W. Rodbard

Үр дүнг сайжруулах
  1. 1
    Management of Type 2 Diabetes – Methods for Addition of Prandial to Basal Insulin

    Management of Type 2 Diabetes – Methods for Addition of Prandial to Basal Insulin -н Helena, W Rodbard, Karolicki, Boris

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах Бүрэн текст авах
    текст
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes

    Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes -н Leigh Perreault, Helena W. Rodbard, Virginia Valentine, Eric L. Johnson

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection

    Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection -н Erin D. Michos, George L. Bakris, Helena W. Rodbard, Katherine R. Tuttle

    Хэвлэсэн 2023
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes

    The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People... -н Helena W. Rodbard, Anne L. Peters, April Slee, Anjun Cao, Shana Traina, Maria Alba

    Хэвлэсэн 2016
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Treatment intensification with an insulin degludec (<scp>IDeg</scp>)/insulin aspart (<scp>IAsp</scp>) co‐formulation twice daily compared with basal <scp>IDeg</scp> and prandial <scp>IAsp</scp> in type 2 diabetes: a randomized, controlled phase <scp>III</scp> trial

    Treatment intensification with an insulin degludec (<scp>IDeg</scp>)/insulin aspart (<scp>IAsp</scp>) co‐formulation twice daily compared with basal <scp>IDeg</scp> and prandial <s... -н Helena W. Rodbard, Bertrand Cariou, Thomas R. Pieber, Lars Endahl, Jeppe Zacho, John Graham Cooper

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin

    Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin -н Helena W. Rodbard, Jochen Seufert, Naresh Aggarwal, A. Cao, Albert Fung, Michael Pfeifer, Maria Alba

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Adding fast‐acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: <scp>A</scp> randomized, 18‐week, open‐label, phase 3 trial (onset 3)

    Adding fast‐acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: <scp>A</scp> randomized, 18‐week, open‐label, phase 3... -н Helena W. Rodbard, Devjit Tripathy, Maricela Vidrio Velázquez, Marek Demissie, Søren C. Tamer, Milivoj Piletič

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Safety and efficacy of insulin degludec/liraglutide (<scp>ID</scp>egLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the <scp>DUAL IV</scp> trial

    Safety and efficacy of insulin degludec/liraglutide (<scp>ID</scp>egLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabete... -н Helena W. Rodbard, Bruce W. Bode, Stewart B. Harris, Ludger Rose, Lucine Lehmann, Henrik Jarlov, Jerry Thurman

    Хэвлэсэн 2016
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes

    Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes -н Bernard Zinman, Athena Philis‐Tsimikas, Bertrand Cariou, Yehuda Handelsman, Helena W. Rodbard, Thue Johansen, Lars Endahl, Chantal Mathieu

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes

    A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes -н Joseph M. Tibaldi, Martin Hadley‐Brown, Andreas Liebl, Steffen Haldrup, Viktor Sandberg, Michael Lyng Wolden, Helena W. Rodbard

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial

    Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled tr... -н Andrew Ahmann, Helena W. Rodbard, Julio Rosenstock, Jorma Lahtela, Luis De Loredo, Karen Tornøe, A. Boopalan, Michael A. Nauck

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial

    Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial -н Helena W. Rodbard, Bertrand Cariou, Bernard Zinman, Yehuda Handelsman, Athena Philis‐Tsimikas, Trine Vang Skjøth, Ashma Rana, Chantal Mathieu

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes

    Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes -н Julio Rosenstock, Juan P. Frías, Helena W. Rodbard, Santiago Tofé, E. Sears, Ruth Huh, Laura Fernández Landó, Hiren Patel

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial

    One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial... -н Stephen Gough, Bruce W. Bode, Vincent Woo, Helena W. Rodbard, Sultan Linjawi, M. Zacho, Pamela D. Reiter, John B. Buse

    Хэвлэсэн 2015
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (<scp>BEGIN</scp>: <scp>VICTOZA ADD‐ON</scp>)

    A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (<scp>BEGIN</scp>: <scp>VICTOZA ADD‐ON</scp>) -н Chantal Mathieu, Helena W. Rodbard, Bertrand Cariou, Yehuda Handelsman, Athena Philis‐Tsimikas, Ann Marie Ocampo Francisco, Ashma Rana, Bernard Zinman

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Is adiposopathy (sick fat) an endocrine disease?

    Is adiposopathy (sick fat) an endocrine disease? -н Harold Bays, J. Michael González-Campoy, Robert R. Henry, Donald A. Bergman, Abbas E. Kitabchi, Alan B. Schorr, Helena W. Rodbard

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

    Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Tr... -н Liana K. Billings, Ankur Doshi, D. Gouet, Alejandra Oviedo, Helena W. Rodbard, Nikolaοs Tentolouris, Randi Grøn, Natalie Halladin, Esteban Jódar

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets

    Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets -н J. Hans DeVries, Stephen C. Bain, Helena W. Rodbard, Jochen Seufert, David A. D’Alessio, Anne Bloch Thomsen, Marcin Zychma, Julio Rosenstock

    Хэвлэсэн 2012
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target

    One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target -н Julio Rosenstock, Helena W. Rodbard, Stephen C. Bain, David A. D’Alessio, Jochen Seufert, Anne Bloch Thomsen, Claus Bo Svendsen, J. Hans DeVries

    Хэвлэсэн 2013
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity

    Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity -н Harold Bays, J. Michael González-Campoy, George A. Bray, Abbas E. Kitabchi, Donald A. Bergman, Alan B. Schorr, Helena W. Rodbard, Robert R. Henry

    Хэвлэсэн 2008
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: